Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters
暂无分享,去创建一个
R. Greil | T. Melchardt | A. Egle | K. Schlick | L. Weiss | T. Magnes | Lukas Ratzinger | Bernhard Jaud